Document Detail


Oral gram-negative bacilli in bone marrow transplant patients given chlorhexidine rinses.
MedLine Citation:
PMID:  2632605     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Fifteen bone marrow transplant (BMT) patients who received three 0.12% chlorhexidine digluconate (CHX) mouthrinses daily for eight weeks were monitored weekly for the occurrence of oral opportunistic Gram-negative bacilli (GNB). Tongue and buccal mucosa were sampled with use of Culturette swabs that were streaked on plates containing selective MacConkey agar. After incubation, colony-forming units were scored and putative GNB classified with use of the API 20E rapid identification system and supplemental biochemical tests. After identification, the susceptibilities of all GNB to CHX were determined by means of a disk diffusion sensitivity assay. Sixty-seven percent (10) of the BMT subjects had at least one GNB-positive tongue culture, and 53% (8) had GNB in samples taken from the buccal mucosa. Of 218 samples taken, 26% and 24% from the tongue and buccal mucosa, respectively, were GNB-positive. The predominant clinical GNB isolates were Enterobacter cloacae (46%) and Klebsiella pneumoniac (30%). Their respective CHX minimum inhibitory concentrations (MICs) were similar to those of ATCC reference strains. Although the CHX MIC values of the clinical GNB isolates were high (less than or equal to 37.5 to less than or equal to 300 micrograms/mL), they were not dependent upon length of exposure to the agent. Therefore, changes in sensitivity or resistance to CHX did not appear to occur. The results suggest that the mouths of BMT patients--and perhaps of other immunosuppressed individuals--should be routinely monitored for GNB, as are other clinically important sites, such as the throat and the urinary and gastro-intestinal tracts.
Authors:
A T Brown; R E Sims; T P Raybould; T T Lillich; P J Henslee; G A Ferretti
Related Documents :
6214995 - In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of bet...
2157025 - Design and characterization of escherichia coli mutants devoid of ap4n-hydrolase activity.
2690615 - In vitro activity of ofloxacin against chlamydia trachomatis.
8619575 - Decreased activity of erythromycin against streptococcus pyogenes in taiwan.
8807285 - Recombination-dependent growth in exonuclease-depleted recbc sbcbc strains of escherich...
23749975 - Chemoreceptor gene loss and acquisition via horizontal gene transfer in escherichia coli.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of dental research     Volume:  68     ISSN:  0022-0345     ISO Abbreviation:  J. Dent. Res.     Publication Date:  1989 Jul 
Date Detail:
Created Date:  1990-05-14     Completed Date:  1990-05-14     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  0354343     Medline TA:  J Dent Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1199-204     Citation Subset:  D; IM    
Affiliation:
Department of Oral Health Science, College of Dentistry, University of Kentucky, Lexington 40536-0084.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Bacillus / drug effects,  isolation & purification
Bone Marrow Transplantation*
Child
Chlorhexidine / analogs & derivatives*,  therapeutic use
Colony Count, Microbial
Female
Gram-Negative Bacteria / drug effects,  isolation & purification*
Humans
Male
Microbial Sensitivity Tests
Middle Aged
Mouth / microbiology*
Mouthwashes / therapeutic use
Chemical
Reg. No./Substance:
0/Mouthwashes; 55-56-1/Chlorhexidine; MOR84MUD8E/chlorhexidine gluconate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Amalgam margin breakdown caused by creep fatigue rupture.
Next Document:  Surface tension and contact angle on enamel of surfactant solutions for caries diagnosis with dyes.